Marwan G. Fakih, MD - Medical Oncologist, Professor, Department of Medical Oncology & Therapeutics Research, Deputy Director, City of Hope Comprehensive Cancer Center, Division Chief, GI Medical Oncology, Co-director, Gastrointestinal Cancer Program
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “Marwan G. Fakih, MD - Medical Oncologist, Professor, Department of Medical Oncology & Therapeutics Research, Deputy Director, City of Hope Comprehensive Cancer Center, Division Chief, GI Medical Oncology, Co-director, Gastrointestinal Cancer Program” inside PodZeus.
Dr. Marwan Fakih, Deputy Director of the City of Hope Comprehensive Cancer Center and Division Chief of GI Medical Oncology, discusses the rising incidence of colorectal cancer in young adults under 50, a trend that has nearly doubled over the past two decades. While screening guidelines have been updated to begin at age 45, Dr. Fakih emphasizes that the absolute number of cases in younger populations remains relatively low, making widespread screening inefficient and potentially risky. He advocates for improved patient and physician education to act on early symptoms like rectal bleeding, which are often dismissed as hemorrhoids. He highlights ongoing research into blood-based biomarkers and non-invasive diagnostics, such as methylation assays, as promising tools for early detection. Dr. Fakih also stresses the importance of clinical trial networks to expand access to cutting-edge treatments and the need for specialized care models for young adult patients, including fertility preservation, psychosocial support, and multidisciplinary teams. He concludes by urging health system leaders to prioritize research infrastructure, clinical trial access, and innovation in oncology to stay ahead of rapid advancements in targeted therapies and immunotherapies.
Screening for colorectal cancer should begin at age 45, but health systems must prioritize education to ensure patients and providers act on early symptoms like rectal bleeding.
Young adult colorectal cancer cases remain rare (about 5% of total cases), so population-wide screening below age 45 is not yet efficient or cost-effective.
Invest in blood-based biomarker tests and non-invasive diagnostics to detect precancerous lesions and early-stage cancer in younger populations.
Build multidisciplinary care teams for young adult patients, including fertility preservation, mental health support, and psychosocial services.
Expand clinical trial access through networked research platforms to bring novel therapies closer to patients and improve standard of care.
…and 1 more takeaway available in PodZeus
Introduction to Dr. Marwan Fakih and City of Hope
Dr. Fakih introduces himself as Deputy Director of City of Hope Comprehensive Cancer Center, a top 10 NCI-designated cancer center with a national footprint. He shares his clinical and academic background, including his 25 years of experience treating GI malignancies and leadership roles at Roswell Park, University of Michigan, and City of Hope.
Rising Colorectal Cancer in Young Adults: Context and Screening Challenges
“If you screen a million people younger than 45, you may only find one case. It's very, very rare to happen that early.”
Innovation in Early Detection and the Role of Research
“We need more research in patients younger than 45 so that we have tests that are easy to implement, associated with low chances of false positivity, and acceptable cost to society.”
Expanding Clinical Trial Access and Research Networks
“We owe it to our patients to get those studies closer to them. Not every patient has the means to come to a faraway comprehensive cancer center.”
Care Models for Young Adult Cancer Patients
“You want to save not just the patient, you want to save the soul. You really have to address all the physical, psychosocial, and social issues associated with cancer.”
“You want to save not just the patient, you want to save the soul. You really have to address all the physical, psychosocial, and social issues associated with cancer.”
“We need more research in patients younger than 45 so that we have tests that are easy to implement, associated with low chances of false positivity, and acceptable cost to society.”
“If you screen a million people younger than 45, you may only find one case. It's very, very rare to happen that early.”
Host
Guest
Marwan G. Fakih
person
City of Hope Comprehensive Cancer Center
organization
KRAS
other
Cologuard
product
Immunotherapy
other
National Cancer Institute
organization
Phoenix, Arizona
place
Atlanta, Georgia
place
Chicago
place
RAS
other
How AI is Revolutionizing Capital Planning and Supply Chain in Health Systems
Becker’s Healthcare Podcast • 11m • 3/31/2026
Leading with Purpose, Trust, and Authenticity with Meeta Gandhi
Becker’s Healthcare Podcast • 20m • 3/31/2026
How Health Systems Can Validate ROI and Successfully Scale Ambient AI Solutions from Pilot Programs to Enterprise-Wide Impact
Becker’s Healthcare Podcast • 21m • 3/31/2026
Leading Through Crisis and Continuous Improvement with Jeff Flaks
Becker’s Healthcare Podcast • 21m • 4/1/2026
Inside a Decade of Collaboration Between Banner Health and University of Arizona
Becker’s Healthcare Podcast • 24m • 4/1/2026
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “Marwan G. Fakih, MD - Medical Oncologist, Professor, Department of Medical Oncology & Therapeutics Research, Deputy Director, City of Hope Comprehensive Cancer Center, Division Chief, GI Medical Oncology, Co-director, Gastrointestinal Cancer Program” inside PodZeus.
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime
